Park 7: A Novel Therapeutic Target for Macrophages in Sepsis-Induced Immunosuppression

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.02632
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

HSP-Target of Therapeutic Agents in Sepsis Treatment

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

GPR35 as a Novel Therapeutic Target

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2011English

When Host Defense Goes Awry: Modeling Sepsis-Induced Immunosuppression

Drug Discovery Today: Disease Models
Drug DiscoveryMolecular Medicine
2012English

AMPD1: A Novel Therapeutic Target for Reversing Insulin Resistance

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2014English

Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages

Cell
BiochemistryGeneticsMolecular Biology
2018English

Αvβ1 Integrin as a Novel Therapeutic Target for Tissue Fibrosis

Annals of Translational Medicine
Medicine
2016English

KCa3.1 Ion Channel: A Novel Therapeutic Target for Corneal Fibrosis

PLoS ONE
Multidisciplinary
2018English

Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease?

Molecular Neurobiology
NeuroscienceNeurologyCellularMolecular Neuroscience
2010English

STAT5b in LGL Leukemia &Ndash; A Novel Therapeutic Target?

Oncotarget
Oncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy